PGR and breast carcinoma: In TMA and TCGA data sets, expression levels of HER3 mRNA/protein in TNBC were higher in LAR and M than BL1 and BL2, with similar levels as ER+/PR+/HER2− and HER2+ breast cancer subtypes.